Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.09.2017 | Case report

Rivaroxaban

Prolonged INR: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

An 85-year-old man developed prolonged INR following administration of rivaroxaban [time to reaction onset not stated]. He had a history of atrial fibrillation and was receiving rivaroxaban [route and dosage not stated]. He had a disturbed coagulation profile due to development of a prolonged INR of 3.3 [outcome not stated]. …
Literatur
Zurück zum Zitat Muszynski T, et al. The aptusTM heli-fxTM endoanchorTM system - the innovative endovascular repair method for the patient with postevar type ia endoleak. Acta Neuropsychologica 15: 181-187, No. 2, 2017 - PolandCrossRef Muszynski T, et al. The aptusTM heli-fxTM endoanchorTM system - the innovative endovascular repair method for the patient with postevar type ia endoleak. Acta Neuropsychologica 15: 181-187, No. 2, 2017 - PolandCrossRef
Metadaten
Titel
Rivaroxaban
Prolonged INR: case report
Publikationsdatum
01.09.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-36129-3

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Zidovudine

Case report

Rituximab

Case report

Trastuzumab

Case report

Bupropion